Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (201-210 of 343) with videos related to

Pageof 35
Sort By:
American Journal of Hematology|July 15, 2016
"All the soarings of my mind begin in my blood:" central nervous system complication of Waldenström macroglobulinemiaSeth N Levin, Claudio M de Gusmao, Mark R Etherton, et al.
British Journal of Haematology|February 16, 2017
Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panelShirley D'Sa, Marie José Kersten, Jorge J Castillo, et al.
Leukemia & Lymphoma|October 27, 2025
Prognostic relevance of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis and dose-response evidenceRafael Pichardo-Rodriguez, José M Vela-Ruiz, Luis Villela, et al.
Leukemia|February 3, 2026
Off-trial outcomes of zanubrutinib in Waldenström macroglobulinemia: the prognostic impact of CXCR4 and TP53 alterationsAlberto Guijosa, Nicholas Tsakmaklis, Margaret Kobs, et al.
Leukemia & Lymphoma|September 6, 2023
Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibitionBonnie W Leung, Christopher J Fay, Jordan T Said, et al.
British Journal of Haematology|January 14, 2015
The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cellsYang Cao, Guang Yang, Zachary R Hunter, et al.
Journal of Translational Medicine|June 21, 2013
Cellular immunotherapy for refractory hematological malignanciesJohn L Reagan, Loren D Fast, Howard Safran, et al.
American Journal of Hematology|July 16, 2011
EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from PeruBrady E Beltran, Jorge J Castillo, Domingo Morales, et al.
British Journal of Haematology|April 14, 2016
Targeting Myddosome Assembly in Waldenstrom MacroglobulinaemiaXia Liu, Zachary R Hunter, Lian Xu, et al.
American Journal of Hematology|September 9, 2014
Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from PeruBrady E Beltrán, Iván Maza, Celia B Moisés-Alfaro, et al.
Pageof 35

Showing results (201-210 of 343) with videos related to

Sort By:
Pageof 35
American Journal of Hematology|July 15, 2016
"All the soarings of my mind begin in my blood:" central nervous system complication of Waldenström macroglobulinemiaSeth N Levin, Claudio M de Gusmao, Mark R Etherton, et al.
British Journal of Haematology|February 16, 2017
Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panelShirley D'Sa, Marie José Kersten, Jorge J Castillo, et al.
Leukemia & Lymphoma|October 27, 2025
Prognostic relevance of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis and dose-response evidenceRafael Pichardo-Rodriguez, José M Vela-Ruiz, Luis Villela, et al.
Leukemia|February 3, 2026
Off-trial outcomes of zanubrutinib in Waldenström macroglobulinemia: the prognostic impact of CXCR4 and TP53 alterationsAlberto Guijosa, Nicholas Tsakmaklis, Margaret Kobs, et al.
Leukemia & Lymphoma|September 6, 2023
Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibitionBonnie W Leung, Christopher J Fay, Jordan T Said, et al.
British Journal of Haematology|January 14, 2015
The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cellsYang Cao, Guang Yang, Zachary R Hunter, et al.
Journal of Translational Medicine|June 21, 2013
Cellular immunotherapy for refractory hematological malignanciesJohn L Reagan, Loren D Fast, Howard Safran, et al.
American Journal of Hematology|July 16, 2011
EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from PeruBrady E Beltran, Jorge J Castillo, Domingo Morales, et al.
British Journal of Haematology|April 14, 2016
Targeting Myddosome Assembly in Waldenstrom MacroglobulinaemiaXia Liu, Zachary R Hunter, Lian Xu, et al.
American Journal of Hematology|September 9, 2014
Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from PeruBrady E Beltrán, Iván Maza, Celia B Moisés-Alfaro, et al.
Pageof 35